Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Stomach Neoplasms 5Recurrence 2Neoplasms 2Lymphoma 2Melanoma 1Lymphoma, Mantle-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Hematologic Neoplasms 1Helicobacter Infections 1Gastrointestinal Hemorrhage 1Gastritis, Atrophic 1Dyspepsia 1Cholangiocarcinoma 1COVID-19 1Advanced Solid Tumors 1Adenocarcinoma 1

Interventions

ofatumumab 10Rituximab 6ibrutinib 5Cyclophosphamide 5fludarabine phosphate 4Bendamustine Hydrochloride 4fludarabine 3Lenalidomide 3Alemtuzumab 3spebrutinib 2navitoclax 2acalabrutinib 2KW-2478 2venetoclax 1tirabrutinib 1obinutuzumab 1idelalisib 1dinaciclib 1Tablets 1Stem Cell Transplantation 1Rabeprazole 1Pentostatin 1Metronidazole 1Methylprednisolone 1Magnetic Resonance Imaging 1MLN 8237 1Leukapheresis 1Lansoprazole 1Itraconazole 1Immunotherapy, Adoptive 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, B-Cell × Rabeprazole × Clear all
NCT06787131 2025-12-05

Clinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Administration of ZE50-0134 at 5 Dose Levels in Healthy Volunteers

Lomond Therapeutics Holdings, Inc.

Phase 1 Completed
104 enrolled
LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡